| Literature DB >> 34127931 |
Matthew Pears1, Susanna Kola-Palmer1, Liane Beretta De Azevedo2.
Abstract
Objective: The primary aim of this study was to investigate the association between physical activity (PA) and sitting time on adults' mental health (i.e., depression, anxiety and wellbeing) and the influence of mediators and confounders.Entities:
Keywords: Anxiety; Depression; Pandemic; Regression; Sedentary behaviour; Wellbeing
Year: 2021 PMID: 34127931 PMCID: PMC8190724 DOI: 10.1007/s11332-021-00791-2
Source DB: PubMed Journal: Sport Sci Health ISSN: 1824-7490
Fig. 1CONSORT diagram of participation
Participants demographics consisting of gender, ethnicity, employment status, level of education, children in the house, outdoor space, and previous health condition
| Variable | ||
|---|---|---|
| Sex | ||
| Female | 208 | 74.8 |
| Male | 68 | 24.5 |
| Ethnicity | ||
| White | 222 | 79.9 |
| Minority ethnicity | 55 | 19.8 |
| Employment status | ||
| Student or economically inactive | 129 | 46.4 |
| Employed | 147 | 52.9 |
| House income | ||
| Over £40 k per year | 108 | 38.8 |
| £30-£40 k per year | 47 | 16.9 |
| £20-£30 k per year | 36 | 12.9 |
| £10-£20 k per year | 35 | 12.6 |
| Below £10 k per year | 48 | 17.3 |
| Children in house | ||
| No children | 182 | 65.5 |
| Children | 96 | 34.5 |
| Outdoor space | ||
| Yes | 244 | 87.8 |
| No | 34 | 12.2 |
| Presence of health condition | ||
| One or more health condition | 99 | 35.6 |
| No health condition | 174 | 62.6 |
| COVID symptom presence | ||
| Yes | 46 | 16.2 |
| No | 238 | 83.8 |
| Previous diagnosis of mood or anxiety disorder | ||
| Mood disorder | 75 | 26.4 |
| Anxiety | 77 | 27.1 |
COVID-19 symptoms considered here are high temperature, a new continuous cough and loss or change to sense of smell or taste
Combined effects of sedentary behaviour and physical activity on anxiety, depression, and wellbeing
| Depression | Anxiety | Wellbeing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CI | CI | CI | ||||||||
| High sitting time and low physical activity. | 65 (25) | Reference | Reference | Reference | ||||||
| High sitting time and moderate or high physical activity. | 53 (20) | − 0.41 | − 2.591.7 | 0.713 | 0.46 | − 0.56, 1.48 | 0.374 | 0.26 | − 0.72, 1.24 | 0.608 |
| Low sitting time and low physical activity. | 51 (19) | − 2.7 | − 4.88, − 0.52 | 0.016* | − 0.09 | − 1.11, − 0.93 | 0.863 | 0.65 | − 0.33, 1.63 | 0.196 |
| Low sitting time and moderate or high physical activity. | 95 (36) | − 2.9 | 4.74, − 1.06 | − 0.001* | − 0.07 | − 0.92, 0.79 | 0.88 | 1.23 | 0.41, 2.06 | 0.004 |
High sitting time ≥ 8 h day; low sitting time < 8 h day; moderate or high physical activity ≥ 600 MET·min–1 week–1; low physical activity < 600 MET·min−1 week−1
Association between work-related, on depression, anxiety, and wellbeing scores
| Total depression Score | Total anxiety score | Total subjective Wellbeing score | |||
|---|---|---|---|---|---|
| Work related PA | − 0.009 (− 0.21, 0.03 | − 0.04 (− 0.16, 0.08) | 0.016 (0.05, 0.28) | ||
| 0.15 | 0.553 | 0.007* | |||
| Transportation PA | − 0.07 (− 0.19, − 0.05) | − 0.02 (− 0.1, 0.13) | 0.08 (− 0.04, 0.2) | ||
| 0.257 | 0.799 | 0.171 | |||
| Domestic and garden PA | − 0.13 (− 0.25, − 0.01) | − 0.08 (− 0.2, − 0.04) | 0.014 (0.02, 0.25) | ||
| 0.031* | 0.165 | 0.024* | |||
| Leisure-time PA | − 0.16 (− 0.27, − 0.04) | − 0.06 (− 0.18, − 0.06) | 0.17 (0.05, 0.28) | ||
| 0.009* | 0.309 | 0.006* |
*Statistically significant
Hierarchical multiple regression analysis for correlates of depression scores
| β | SE | CI 95% ( | ||||
|---|---|---|---|---|---|---|
| Step 1 | 0.33*** | |||||
| Age | − 0.22** | − 0.12 | 0.04 | − 0.19/− 0.04 | ||
| Gender | − 0.11 | − 1.63 | 0.85 | − 3.31/0.06 | ||
| Ethnicity | 0.13* | 2.17 | 0.97 | 0.26/4.09 | ||
| Employment | 0.00 | 0.01 | 0.94 | − 1.84/1.86 | ||
| Income > 40 k | ||||||
| < 10 k | 0.18* | 3.15 | 1.31 | 0.58/5.73 | ||
| 10–20 k | 0.08 | 1.49 | 1.30 | − 1.06/4.04 | ||
| 20–30 k | 0.08 | 1.55 | 1.21 | − 0.84/3.94 | ||
| 30–40 k | 0.06 | 0.98 | 1.03 | − 1.05/3.00 | ||
| Comorbid health condition | 0.24*** | 3.10 | 0.83 | 1.47/4.72 | ||
| COVID symptoms | 0.08 | 1.38 | 0.97 | − 0.53/3.30 | ||
| Ever diagnosed mood disorder | 0.26*** | 3.59 | 0.88 | 1.86/5.33 | ||
| Step 2 | 0.34*** | 0.01 | ||||
| Age | − 0.21** | − 0.11 | 0.04 | − 0.18/− 0.04 | ||
| Gender | − 0.10 | − 1.52 | 0.85 | − 3.19/0.15 | ||
| Ethnicity | 0.11 | 1.75 | 0.98 | − 0.18/3.69 | ||
| Employment | 0.02 | 0.23 | 0.94 | − 1.61/2.08 | ||
| Income > 40 k | ||||||
| < 10 k | 0.18* | 3.09 | 1.29 | 0.54/5.64 | ||
| 10–20 k | 0.10 | 1.84 | 1.29 | − 0.71/4.40 | ||
| 20–30 k | 0.08 | 1.50 | 1.20 | − 0.71/3.87 | ||
| 30–40 k | 0.06 | 0.93 | 1.02 | − 1.08/2.93 | ||
| Comorbid health condition | 0.23*** | 2.96 | 0.82 | 1.34/4.57 | ||
| COVID symptoms | 0.20 | 1.76 | 0.98 | − 0.16/3.69 | ||
| Ever diagnosed mood disorder | 0.25** | 3.54 | 0.87 | 1.82/5.26 | ||
| Physical activity | − 0.13* | − 0.04 | 0.02 | − 0.08/− 0.01 | ||
| Step 3 | 0.42*** | 0.08 | ||||
| Age | − 0.18** | − 0.09 | 0.03 | − 0.16/− 0.03 | ||
| Gender | − 0.13* | − 1.91 | 0.80 | − 3.48/− 0.33 | ||
| Ethnicity | − 0.07 | 1.10 | 0.93 | − 0.73/2.93 | ||
| Employment | 0.04 | 0.51 | 0.88 | − 1.23/2.24 | ||
| Income > 40 k | ||||||
| < 10 k | 0.16* | 2.87 | 1.21 | 0.48/5.26 | ||
| 10–20 k | 0.08 | 1.57 | 1.22 | − 0.83/3.96 | ||
| 20–30 k | 0.08 | 1.50 | 1.13 | − 0.72/3.72 | ||
| 30–40 k | 0.04 | .66 | 0.96 | − 1.22/2.55 | ||
| Comorbid health condition | 0.22*** | 2.82 | 0.77 | 1.30/4.33 | ||
| COVID symptoms | 0.06 | 1.00 | 0.93 | − 0.82/2.83 | ||
| Ever diagnosed mood disorder | 0.22** | 3.05 | 0.82 | 1.43/4.67 | ||
| Physical activity | 0.01 | 0.00 | 0.02 | − 0.04/0.04 | ||
| Sitting time | 0.33*** | 0.01 | 0.00 | 0.01/0.01 |
Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001
Hierarchical multiple regression analysis results for correlates of anxiety scores
| β | SE | CI 95% ( | ||||
|---|---|---|---|---|---|---|
| Step 1 | 0.31*** | |||||
| Age | − 0.19** | − 0.03 | 0.01 | − 0.05/− 0.01 | ||
| Gender | − 0.24*** | − 1.07 | 0.26 | − 1.59/− 0.56 | ||
| Ethnicity | − 0.02 | − 0.12 | 0.29 | − 0.70/0.46 | ||
| Employment | 0.03 | 0.12 | 0.29 | − 0.45/0.68 | ||
| Income > 40 k | ||||||
| < 10 k | 0.15* | 0.80 | 0.39 | 0.03/1.58 | ||
| 10–20 k | 0.10 | 0.59 | 0.39 | − 0.18/1.36 | ||
| 20–30 k | 0.05 | 0.30 | 0.37 | − 0.43/1.02 | ||
| 30–40 k | 0.07 | 0.37 | 0.31 | − 0.25/0.98 | ||
| Comorbid health condition | 0.16** | 0.63 | 0.23 | 0.17/1.09 | ||
| COVID symptoms | − 0.01 | − 0.03 | 0.30 | − 0.61/0.55 | ||
| Ever diagnosed anxiety disorder | 0.26*** | 1.10 | 0.25 | 0.61/1.59 | ||
| Step 2 | 0.31*** | 0.00 | ||||
| Age | − 0.19** | − 0.03 | 0.01 | − 0.05/0.01 | ||
| Gender | − 0.24*** | − 1.07 | 0.26 | − 1.59/− 0.56 | ||
| Ethnicity | − 0.02 | − 0.12 | 0.30 | − 0.71/0.48 | ||
| Employment | 0.03 | .12 | 0.29 | − 0.45/0.68 | ||
| Income > 40 k | ||||||
| < 10 k | 0.15* | 0.80 | 0.39 | 0.03/1.58 | ||
| 10–20 k | 0.10 | 0.59 | 0.40 | − 0.19 /1.37 | ||
| 20–30 k | 0.05 | 0.30 | 0.37 | − 0.43/1.02 | ||
| 30–40 k | 0.07 | 0.37 | 0.31 | − 0.24 /− 0.25 | ||
| Comorbid health condition | 0.16*** | 0.63 | 0.24 | 0.16 /1.09 | ||
| COVID symptoms | − 0.01 | − 0.03 | 0.30 | − 0.62/0.56 | ||
| Ever diagnosed anxiety disorder | 0.26*** | 1.10 | 0.25 | 0.60/1.59 | ||
| Physical activity | 0.00 | − 02.56 | 0.01 | − 0.01/.01 | ||
| Step 3 | 0.32*** | 0.01 | ||||
| Age | − 0.18* | − 0.03 | 0.01 | − 0.05/− 0.01 | ||
| Gender | − 025*** | − 1.12 | 0.26 | − 1.63/− 0.60 | ||
| Ethnicity | − .04 | − 0.18 | 0.30 | − 0.77/0.41 | ||
| Employment | 0.04 | 0.14 | 0.29 | − 0.43/0.71 | ||
| Income > 40 k | ||||||
| < 10 k | 0.15* | 0.77 | 0.39 | − 0.00/1.55 | ||
| 10–20 k | 0.10 | 0.77 | 0.39 | − 0.22/1.34 | ||
| 20–30 k | 0.05 | 0.30 | 0.37 | − 0.43/1.02 | ||
| 30–40 k | 0.07 | 0.34 | 0.31 | − 0.28/.95 | ||
| Comorbid health condition | 0.15* | 0.60 | 0.23 | 0.14/1.06 | ||
| COVID symptoms | − .02 | -.10 | .30 | − 0.70/0.49 | ||
| Ever diagnosed anxiety disorder | 0.25** | 1.05 | .25 | 0.56/1.55 | ||
| Physical activity | 0.05 | .01 | .01 | 0.02/− 0.03 | ||
| Sitting time | 0.11 | .00 | .00 | 0.00/0.14 |
Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001
Hierarchical multiple regression analysis for correlates of wellbeing scores
| β | SE | CI 95% ( | ||||
|---|---|---|---|---|---|---|
| Step 1 | 0.22*** | |||||
| Age | 0.12 | 0.03 | 0.02 | − 0.01/0.06 | ||
| Gender | − 0.01 | − 0.08 | 0.37 | − 0.82/0.65 | ||
| Ethnicity | 0.02 | 0.13 | 0.42 | − 0.71/0.96 | ||
| Employment | − 0.02 | − 0.08 | 0.41 | − .89/0.73 | ||
| Income > 40 k | ||||||
| < 10 k | − 0.16 | -− 1.10 | .57 | − 2.22/0.01 | ||
| 10–20 k | − 0.01 | − 0.04 | 0.56 | 1.15/1.07 | ||
| 20–30 k | − 0.02 | − 0.12 | 0.53 | − 1.15/0.92 | ||
| 30–40 k | − 0.06 | − 0.40 | 0.45 | − 1.28/0.48 | ||
| Comorbid health condition | − 0.25*** | − 1.30 | 0.36 | − 2.01/0.59 | ||
| COVID symptoms | 0.01 | 0.05 | 0.42 | − 0.78/0.89 | ||
| Ever diagnosed mood disorder | − 0.26*** | − 1.47 | 0.48 | − 2.27/− 0.66 | ||
| Ever diagnosed anxiety disorder | .07 | 0.37 | 0.38 | − 0.39/1.12 | ||
| Step 2 | 0.23*** | 0.01 | ||||
| Age | 0.11 | 0.02 | 0.02 | – 0.01/.05 | ||
| Gender | –0.02 | – 0.13 | 0.37 | – 0.87/.60 | ||
| Ethnicity | 0.05 | 0 | 0.43 | – 0.54/1.14 | ||
| Employment | –0.04 | – 0.18 | 0.41 | – 0.99/.63 | ||
| Income > 40 k | ||||||
| < 10 k | – 0.15 | – 1.08 | 0.56 | – 2.19/.03 | ||
| 10–20 k | – 0.02 | – .19 | 0.56 | – 1.30/.93 | ||
| 20–30 k | – 0.01 | – .09 | 0.52 | – 1.13/.94 | ||
| 30–40 k | – 0.06 | – .38 | 0.44 | – 1.25/.49 | ||
| Comorbid health condition | − 0.24*** | − 1.24 | 0.36 | − 1.62/− 0.53 | ||
| COVID symptoms | − 0.01 | − 0.10 | 0.43 | − 0.94/0.74 | ||
| Ever diagnosed mood disorder | − 0.25*** | − 1.43 | 0.41 | − 2.23/0.63 | ||
| Ever diagnosed anxiety disorder | 0.06 | 0.34 | 0.38 | − 0.41/1.09 | ||
| Physical activity | 0.13* | 0.02 | 0.01 | 0.00/0.04 | ||
| Step 3 | 0.27*** | 0.04 | ||||
| Age | 0.09 | 0.02 | 0.02 | − 0.01/.05 | ||
| Gender | − 0.00 | − 0.02 | 0.37 | − 0.73/.70 | ||
| Ethnicity | 0.07 | 0.49 | 0.42 | − 0.34/1.31 | ||
| Employment | − 0.05 | − 0.24 | 0.40 | − 1.03/0.55 | ||
| Income > 40 k | ||||||
| < 10 k | − 0.14 | − 1.01 | 0.55 | − 2.10/0.07 | ||
| 10–20 k | − 0.02 | − 0.11 | 0.55 | − 1.20/0.97 | ||
| 20–30 k | − 0.01 | − 0.10 | 0.51 | − 1.10/0.91 | ||
| 30–40 k | − 0.05 | − 0.30 | 0.43 | − 1.16/0.55 | ||
| Comorbid health condition | − 2.30*** | − 1.21 | 0.35 | − 1.90/− 0.52 | ||
| COVID symptoms | 0.02 | 0.10 | 0.42 | − 0.73/0.93 | ||
| Ever diagnosed mood disorder | − 0.24*** | − 1.33 | 0.40 | − 2.11/− 0.55 | ||
| Ever diagnosed anxiety disorder | 0.08 | 0.43 | 0.37 | − 0.30/1.17 | ||
| Physical activity | 0.04 | 0.01 | 0.01 | − 0.01/0.02 | ||
| Sitting time | − 0.23*** | − 0.00 | 0.00 | − 0.00/− 0.00 |
Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001